Recent Recurrent Liver Cancer News

Liver Cancer Drug Livatag® Granted U.S. Food and Drug Administration Fast Track Designation

(May 27, 2014)

The drug Livatag® (doxorubicin Transdrug™) has received fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of primary liver cancer after treatment with Nexavar®... Continue Reading


Cabozantinib Shows Promise against Bone Metastases

(May 31, 2011)

The investigational drug cabozantinib is showing promise against several types of advanced cancer, and may also reduce or eliminate bone metastases (cancer that has spread to the bone) in some patients.... Continue Reading


Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain

(November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival... Continue Reading